TezepelumabMeSH Supplementary Concept

https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma

---
https://www.has-sante.fr/jcms/p_3539123/fr/tezspire-tezepelumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
chronic disease
tezepelumab
biological therapy

---
https://www.has-sante.fr/jcms/p_3479050/fr/tezspire-tezepelumab-asthme
2023
France
evaluation of the transparency committee
asthma
Asthma
tezepelumab
tezepelumab
tezspire
asthma
Tezepelumab
Asthma Pathway
asthma, nos

---
https://www.has-sante.fr/jcms/p_3448876/fr/tezspire-tezepelumab-asthme
2023
false
false
false
France
tezepelumab
evaluation of the transparency committee
tezepelumab
asthma

---
https://ansm.sante.fr/tableau-acces-derogatoire/tezspire#
2023
false
false
false
France
French
tezepelumab
asthma
adult
adolescent
guidelines for drug use
evaluation of the transparency committee
continuity of patient care
injections, subcutaneous
forms
tezepelumab

---
https://www.has-sante.fr/jcms/p_3402822/fr/tezspire-tezepelumab-asthme
2022
false
false
false
France
adult
adolescent
treatment outcome
insurance, health, reimbursement
tezepelumab
anti-asthmatic agents
injections, subcutaneous
antibodies, monoclonal, humanized
evaluation of the transparency committee
tezepelumab
tezspire
asthma

---
https://ansm.sante.fr/tableau-acces-derogatoire/tezepelumab-astrazeneca-210-mg-solution-injectable-en-seringue-preremplie
2022
false
false
false
France
French
drug information
tezepelumab
asthma
adult
adolescent
tezepelumab

---
https://www.has-sante.fr/jcms/p_3333360/fr/tezepelumab-tezepelumab
https://www.has-sante.fr/jcms/p_3333427/fr/decision-n-2022-0128/dc/sem-du-14-avril-2022-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-autorisation-d-acces-precoce-de-la-specialite-tezepelumab
2022
false
false
false
France
evaluation of the transparency committee
tezepelumab
tezepelumab

---
https://www.cadth.ca/fr/tezepelumab
2022
false
false
false
Canada
French
English
drug evaluation
asthma
tezepelumab

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tezspire
2022
false
false
false
Netherlands
French
English
treatment outcome
tezepelumab
tezepelumab
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug therapy, combination
asthma
adult
adolescent
Severe asthma (disorder)
injections, subcutaneous
tezepelumab
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---